Lindbrook Capital, LLC - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 3 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,462
-21.3%
782
+5.7%
0.00%
Q2 2023$1,857
-74.5%
740
-82.2%
0.00%
-100.0%
Q1 2023$7,291
+479.6%
4,166
+1307.4%
0.00%
Q4 2022$1,258296
+100.0%
0.00%
Q4 2021$0
-100.0%
148
-43.7%
0.00%
Q3 2021$1,000
-80.0%
263
-61.3%
0.00%
-100.0%
Q2 2021$5,0000.0%680
-22.5%
0.00%0.0%
Q1 2021$5,000
+25.0%
877
+4.0%
0.00%0.0%
Q4 2020$4,0008430.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS (UK) LLP 2,667,350$7,922,0000.33%
Polar Capital LLP 4,500,000$13,365,0000.12%
Inscription Capital, LLC 17,000$50,0000.03%
BBR PARTNERS, LLC 50,000$149,0000.02%
Checchi Capital Advisers, LLC 20,000$59,0000.01%
Cornerstone Investment Partners, LLC 34,825$103,0000.01%
ACADIAN ASSET MANAGEMENT LLC 49,257$146,0000.00%
Renaissance Technologies 361,112$1,073,0000.00%
HSBC HOLDINGS PLC 150,975$448,0000.00%
CAPTRUST FINANCIAL ADVISORS 11,000$35,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders